We investigated the expression of heat shock protein 27 (HSP27) at intermediate stages of a cutaneous tumor induced by UVB-irradiation stress (290-380 nm, max. 312 nm) using an immunostaining method.
Heat shock protein 27 (HSP27), a small stress protein, is a highly conserved low molecular weight protein related to the a-crystallin proteins and a member of the heat shock protein (HSP) family. HSP27 is phosphorylated and overexpressed in response to oxidative stress, thermal stress, inflammatory cytokines, and retinoic acid. 1) HSP27 shares biochemical properties, such as oligomerization and phosphorylation, with the other members of the HSP family. HSP27 exists as large, dynamic cytoplasmic aggregates, with native molecular masses ranging from 100 to 800 kDa. 2, 3) The accumulated HSP27 protein in cytoplasm may act as molecular chaperon, 4) display actin capping/decapping 5, 6) and modulate redox parameters. 7) HSP27 is, in addition to its protective function in heat shock and other types of stress, linked to epidermal cell differentiation 8) and growth arrest. 9, 10) HSP27 is distributed in human tissues such as breast, uterus, oviduct vagina and skin. 11, 12) Kindas-Mugge and Trautinger 13) showed by in vitro experiments that the level of HSP27 expression was correlated with the state of differentiation of normal human epidermal keratinocytes, HNK cells. Furthermore, they 14) showed that no HSP27 expression was detected in human normal epidermal basal cells and human SCC. Gandour-Edwards et al. 15) also reported that SCC demonstrated only weak cytoplasmic staining throughout the infiltrating tumor. These results suggest that HSP27 may be regarded as a marker of differentiation in epidermal malignancy.
The purpose of the experiments reported here was to determine whether or not HSP27 expression correlates to differentiation levels in subsequent tumor progression to malignant SCC induced by chronic UVB-exposure.
MATERIALS AND METHODS

Animals
Female hairless mice (SKH-hr 1; Sankyo Laboservice Inc., Tokyo), 5 weeks old at the beginning of the experiment, were used. They were housed under standard conditions (fluorescent light 12 h/d, room temperature 23°C and relative humidity 45-55%) and fed on a commercial diet with water ad libitum. The animal experiment protocol was approved by the Committee of the Ethics of Animal Experiments of Kyoritsu College of Pharmacy.
UVB Irradiation Cages (20ϫ15ϫ5 cm), containing five mice each, were placed under UV lamps (HP-15M, 285-380 nm, max. 312 nm; Atto Co., Tokyo). The animals were exposed to UVB at a dose of 2 kJ/m 2 three times a week; the distance from the lamps to the animals backs was 35 cm. The exposure time was less than 10 min and no detectable heat was produced during irradiation. The UVB doses were determined at 312 nm with an Atto radiometer (ATR; Atto Co., Tokyo). At 15, 20 and 25 weeks of chronic exposure, 10 animals were sacrificed 1 week after the last irradiation. Small tumors (Ͻ1 mm) appeared in the skin of mice 8-10 weeks after the animals were exposed to UVB irradiation. 16 ) By 25 weeks the small tumors were present in all mice. At week 15, 20 or 25 of exposure, the number of tumors per mouse was 5.8Ϯ2.3, 15.1Ϯ3.7 or 25.2Ϯ4.9 per mouse, respectively. The mean number of tumors that were more than 5 mm in diameter was 3.0Ϯ2.4 per mouse by 25 weeks. The smaller tumors were diagnosed to be papilloma. The larger tumors were diagnosed as SCC.
Immunohistochemical Assay For HSP27 immunohistochemistry, 5-mm frozen sections in embedding medium for frozen tissues specimens (O.T.C. 4583 compound; Miles Inc., Elkhart, IN) were cut by a cryostat (CM 1800, Leica Instuments, Nussloch, Germany) from the appropriate specimens and mounted on glass. For double staining, specimens were submitted in 10% buffered formalin, processed by standard methods, and embedded in paraffin for the tissues sectioning. The frozen and deparaffinized sections were examined by immunohistochemical techniques utilizing IgG monoclonal antibodies against HSP25 and cytokeratin 10 (PROGEN BIOTECHINIK GMBH, Heiderberg, Germany) at a dilution of 1 : 500. Briefly, 4-5 mm sections were endogenous peroxidase-blocked by 3% H 2 O 2 in absolute methanol. Blocking with 10% normal goat serum was followed by a biotin-conjugated goat anti-rabbit secondary antibody at a dilution of 1 : 1000. After rinsing with PBS, streptavidin-biotin-peroxidase (Nichirei Co., Tokyo) was applied to achieve a permanent color change in the reactive cells. Im-munostained sections were again stained with hematoxylin and evaluated by light microscopy for reactivity.
HE Staining Dosal skin sections were fixed with 2.5% glutaraldehyde in 0.1 M sodium phosphate buffer for 15 min. For microscopy, the specimen was dehydrated with ethanol and embedded in paraffin. Sections of the fixed specimen were then stained with 1% eosin and hematoxylin (HE).
RESULTS
Immunostaining Analysis
Frozen sections of skin from normal 5 week old mice were examined for HSP27 expression by immunohistochemical methods. As shown in Fig. 1a , cytoplasmic staining patterns indicate constitutive expression of HSP27 in the upper epidermal layers of normal mouse skin. However, basal cells of the epidermis were nonreactive. The distribution pattern of HSP27 was not altered by aging (data not shown). After 15 weeks, HSP27 staining intensity was clearly increased in the upper layers of tumors induced by UVB-exposure (Fig. 1c) , as well as in the cytoplasm of epidermal cells in response to single dose-irradiation, at a dose of 2 kJ/m 2 (Fig. 1b) . In contrast, HSP27 was weakly expressed in bowenoid multilayers of epidermis after 20 weeks of chronic exposure; as indicated by the gradual decrease in staining intensity from upper layers to the basal cells of keratinocytes (Fig. 1d) . All of the larger tumors, identified pathologically as SCC, had faint HSP27 expression after 25 weeks exposure of the upper cell layers in the carcinoma, and where normal stratification seems to be conserved (Fig. 1e) .
Cytokeratin 10 was highly expressed as indicated by strong cytoplasmic staining in the suprabasal keratinocytes of normal mouse skin (Fig. 2a) . The intensity of cytokeratin 10 gradually decreased as tumor growth progressed during continuous UVB-exposure (Figs. 2b and c) . After 25 weeks exposure, many SCCs were completely negative for cytokeratin 10 (Fig. 2c) . The expression pattern in suprabasal keratinocytes resembled that of HSP27 in the epidermis (Figs.  1a, c-e) . Paraffin sections double-stained with HSP27 antibody and hematoxylin were positive for two types of HSP27 in SCCs (Fig. 3) . One type had faint HSP27 staining in the well-differentiated carcinomatous area (*), where cells have relatively great variability in nuclear size. The other type had no staining in the poorly-differentiated carcinomatous area that consisted of immature large basaloid cells containing a chromatin rich round or ovoid nucleus. After 25 weeks of exposure, many SCCs showed the same HSP27 staining pattern. These results indicate that HSP27 expression may decrease with less differentiated tumors.
DISCUSSION
In the present study, we showed that the amount of HSP27 declined significantly as epithelial carcinoma growth progressed upon UVB exposure. This experimental finding confirmed earlier immunochistochemical results in human materials. In human skin tumors, basal cell carcinoma, SCC and Bowen's disease, HSP27 was weakly expressed or undetectable. 14, 15) Recently, Kawagishi et al. 21) also showed that HSP27 expression was reduced in patients with SCC of the esophagus. In contrast, increased HSP27 expression was found to be associated with aggressive forms of human breast carcinomas, [22] [23] [24] human ovarian cancer, 25) human endometrial carcinoma, 26) human brain tumors 27, 28) and rat renal tumors. 29) Recently, Garrido et al. 30) demonstrated that overexpression of HSP27 in immunogenic rat colon carcinoma cells increases their tumorigenicity as a result of a decrease in tumor cell ability to undergo apoptosis. Basal cell carcinoma (BCC) is the most frequent non-melanoma skin cancer in humans and is thought to be induced by chronic UV-exposure. 31) Bayerl et al. 32) found HSP27 and bcl-2 positive cells in BCC which might characterize the tumor as relatively benign and slow progressing. These results suggest that there are differences between SCCs and the other types of malignancies in the modulation of HSP27 gene expression. Under unstressed physiological conditions, large amounts of the HSP27 gene mRNA in mice were detected in the stratified squamous epithelia in skin, oesophagus and stomach, and the transitional epithelium in the urinary bladder. 33) However, expression was scarcely detectable in nervous tissues, lymphatic tissues, columnar epithelial cells of digestive tract, and parenchymal cells of the liver, pancreas and kidney. These results suggest that HSP27 expression has high tissue specificity. The specificity may also be associated with differences of HSP27 expression between SCCs and the other types of malignancies.
Kindas-Mugge and Trautinger 13) reported in in vitro experiments that HSP27 was accumulated in a differentiation-dependent manner under growth conditions that induce terminal differentiation. They also showed that in normal human epidermis, HSP27 is expressed in the upper epidermal layers with a cytoplasmic staining pattern, but not in the basal cell layer. 14) Moreover, in fetal human skin, HSP27 could not be detected until the 20th week of gestation. 14) These results suggest accumulation of HSP27 in a differentiation correlated manner in cultured human keratinocytes. In this experiment, lack of HSP27 expression was observed in the poorly differentiated areas of SCC induced by UVB-irradiation, indicating that HSP27 expression may be lower in less differentiated tumors. The distribution pattern of HSP27 resembled that of cytokeratin 10, which reacts only with keratinizing cells of epidermis. Kamishima et al. 34) also reported that HSP27 expression declined in poorly differentiated urinary bladder cancers. These results suggest that HSP27 may be regarded as a marker of differentiation in keratinocytes and the absence of HSP27 in epidermal cells may be a marker for epidermal malignacy.
In conclusion, our experimental results supports clinical evidence which show that a decrease of HSP27 expression is observed in poorly differentiated SCC and that the absence might be a marker of epithelial carcinoma growth progression.
